Satellos Bioscience MSLE
NASDAQ MSLE
$6.75 -0.45 (-6.25%)
At close: Nov 11, 2026 · 4:00 PM EST

Satellos Bioscience (MSLE) Total Liabilities (2023 - 2026)

Updated

Satellos Bioscience (MSLE) recorded Total Liabilities of $5.86 million in the quarter ended Jun 30, 2026, up 28.4% from the prior quarter.

Analysis

Satellos Bioscience (MSLE) Total Liabilities (2023 - 2026) Analysis & Trends

As of Dec 31, 2025, Satellos Bioscience reported Total Liabilities of $4.11 million, up 11.2% from the prior year.

  • Across earlier years, Total Liabilities came in at $3.69 million in the year ended Dec 31, 2024 (+38.6%) and $2.66 million in the year ended Dec 31, 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Liabilities (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 107.80 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 115.90 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 152.26 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 87.83 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 68.11 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 81.70 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 38.37 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 115.70 Bn
10 Satellos Bioscience 109.60 Mn -98.54 Mn - 5.86 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 5.86 Mn
Mar 31, 2026 4.56 Mn
Dec 31, 2025 4.11 Mn
Dec 31, 2024 3.59 Mn
Dec 31, 2023 2.74 Mn
API Access

Satellos Bioscience Total Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-liabilities&ticker=MSLE&period=max&api_key=YOUR_API_KEY